Improved Dissolution Characteristics of Silymarin and Their Bioavailability in Rats
![]() |
Kim, Jeong-Hoon
(Research Laboratories, Dong-A Pharmaceutical Co., Ltd.)
Jang, Sun-Woo (Research Laboratories, Dong-A Pharmaceutical Co., Ltd.) Kweon, Jong-Weon (Research Laboratories, Dong-A Pharmaceutical Co., Ltd.) Kim, Won-Bae (Research Laboratories, Dong-A Pharmaceutical Co., Ltd.) Choi, Yong-Wook (College of Pharmacy, Chung-Ang University) |
1 | K. Parfitt, Martindale, The complete drug reference, 32nd Ed., Pharmaceutical Press, London, PP. 993-994 (1999) |
2 | G. Gatti and E. Pemcca, Plasma concentrations of free and conjugated silybin after oral intake of a Silybin phosphatidy-lcholine complex (silipide) in healthy volunteers, Int. J. Ctin.Pharmacol. Ther., 32, 614-617 (1994) |
3 | E. M. Martinelli, P. Morazzoni, S. Liviio and E. Uberti, Liquid chromatographic assay of silybin in human plasm aand urine, J. Liq. Chromatogr., 14, 1285-1296 (1991) DOI ScienceOn |
4 | R. Weyhennmeyer, H. Mascher and J. Birkmayer, Study on dose linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay, Int. J. Clin.Pharmaco., Ther. Tox., 30, 134-138 (1992) |
5 | B. Rickling, B. Hans, R. Kramarczyk, G. Krumbiegel and R. Weyhenmeyer, Two high performance liquid chromato-graphic assays for the determination of free and total silibinin diasteromers in plasma using column switching with electrochemical detection and reversed phase chromato-graphy with ultraviolet detection, J. Chromatogr. B, 670,267-277 (1995) DOI ScienceOn |
6 | H. Salmi, and S. Sama, Effect of silymarin on chemical, functional and morphological altemtions of the liver. A double-blind controlled study, Scand. J. Gastroenterol., 17, 517-521 (1982) DOI ScienceOn |
7 | P. Ferenci, B. Dragosics, H. Dittrich, H. Frank, L. Benda, H.Lochs, S. Meryn, W. Base and B. Schneider, Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver, J. Hepatol, 9, 105-113 (1989) DOI ScienceOn |
8 | K. Hruby, G. Csornos, M. Fuhrmann and H. Thaler, Chemotheraphy of amantia phalloid poisoning with intravenous silibinin, Human Toxicol, 2, 183-195 (1983) DOI |
9 | P. Morazzoni, M. J. Magistretti, C. Giachetti, and G. Zanolo, Comparative bioavailability of silipide, a new flavanolignan complex in rats, Eur. J. Drug Metab. Pharmacokinet., 17,39-44 (1992) DOI |
10 | D. Lorenz, P. W. Lucker, W. H. Mennicke and N. Wetzelsberger, Pharmacokinetic studies with silymarin in human serum and bile, Meth. and Find. Exptl. Clin. Pharmacol., 6, 655-661 (1984) |
11 | P. Morazzoni, A. Montalbett, S. Malandrino and G. Piffer, Comparative pharmacokinetics of silipide and silymarin in rat, Eur. J Drug Metab. Ph., 18, 289-97 (1993) DOI ScienceOn |
12 | D. Savio, P. Harrasser and G. Basso, Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomized study on silybin, Arzneimiuel-Forsch., 48, 1104-1106 (1998) |
![]() |